journal article Open Access Feb 04, 2026

Society for Maternal‐Fetal Medicine Special Statement: Updated checklists for preeclampsia risk‐factor screening to guide recommendations for prophylactic low‐dose aspirin

Pregnancy Vol. 2 No. 2 · Wiley
View at Publisher Save 10.1002/pmf2.70212
Abstract
Abstract
Prophylactic low‐dose aspirin is recommended to reduce the risk of preeclampsia in pregnant persons with risk factors. Sixteen distinct risk factors are recognized, including elements of current and past medical and obstetrical history, family history, and examination findings. In 2020, the Society for Maternal‐Fetal Medicine published checklists intended to reduce the chance that risk factors might be inadvertently overlooked and to improve the probability of aspirin being recommended for all appropriate candidates. In 2021, the U.S. Preventive Services Taskforce published an updated Recommendation Statement expanding the number of persons for whom aspirin prophylaxis is recommended. Here, the Society for Maternal‐Fetal Medicine presents updated checklists incorporating the new recommendations. We also suggest steps for implementing such a checklist into routine practice. This statement replaces the 2020 Society for Maternal‐Fetal Medicine Special Statement: Checklists for preeclampsia risk‐factor screening to guide recommendations for prophylactic low‐dose aspirin.
Topics

No keywords indexed for this article. Browse by subject →

References
27
[1]
Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis

C. V. Ananth, K. M. Keyes, R. J. Wapner

BMJ 10.1136/bmj.f6564
[2]
Vital Signs: Pregnancy-Related Deaths, United States, 2011–2015, and Strategies for Prevention, 13 States, 2013–2017

Emily E. Petersen, Nicole L. Davis, David Goodman et al.

MMWR. Morbidity and Mortality Weekly Report 10.15585/mmwr.mm6818e1
[9]
Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis

Stéphanie Roberge, Emmanuel Bujold, Kypros H. Nicolaides

American Journal of Obstetrics and Gynecology 10.1016/j.ajog.2017.11.561
[10]
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality

Jillian T. Henderson, Kimberly K. Vesco, Caitlyn A. Senger et al.

JAMA 10.1001/jama.2021.8551
[11]
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality

Karina W. Davidson, Michael J. Barry, Carol M. Mangione et al.

JAMA 10.1001/jama.2021.14781
[12]
American College of Obstetricians and Gynecologists Society for Maternal Fetal Medicine.Low‐Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality. January 21  2026.https://www.acog.org/clinical/clinical‐guidance/practice‐advisory/articles/2021/12/low‐dose‐aspirin‐use‐for‐the‐prevention‐of‐preeclampsia‐and‐related‐morbidity‐and‐mortality.
[16]
American Academy of Pediatrics, American College of Obstetricians and Gynecologists (2017)
[23]
Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study

Roxanne Hastie, Stephen Tong, Anna-Karin Wikström et al.

American Journal of Obstetrics and Gynecology 10.1016/j.ajog.2020.07.023
Metrics
0
Citations
27
References
Details
Published
Feb 04, 2026
Vol/Issue
2(2)
License
View
Cite This Article
Jeny Ghartey, C. Andrew Combs (2026). Society for Maternal‐Fetal Medicine Special Statement: Updated checklists for preeclampsia risk‐factor screening to guide recommendations for prophylactic low‐dose aspirin. Pregnancy, 2(2). https://doi.org/10.1002/pmf2.70212